---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-081419"
form_type: "8-K"
ticker: "IBIO"
cik: "0001420720"
company_name: "iBio, Inc."
filed_at: "2025-08-21T23:59:59+00:00"
generated_at: "2026-05-17T10:47:20.026801+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# iBio prices $50M public offering of pre-funded warrants and Series G/H warrants

## Summary
- Combined offering price $0.699 per unit; gross proceeds ~$50M before underwriting discounts and expenses.
- Pre-funded warrants exercisable immediately at $0.001; Series G warrants at $0.70 expire upon trial initiation milestone or 5 years.
- Series H warrants expire 4 years after closing; total potential additional proceeds of ~$50M if all warrants exercised for cash.
- Net proceeds to advance preclinical cardiometabolic programs IBIO-610 (myostatin/activin A bispecific) and IBIO-600.
- Closing expected August 22, 2025; 90-day lock-up on share issuance for company and insiders.

## SEC filing metadata
- accession: 0001104659-25-081419
- form_type: 8-K
- ticker: IBIO
- cik: 0001420720
- company_name: iBio, Inc.
- filed_at: 2025-08-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420720/000110465925081419/0001104659-25-081419-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420720/000110465925081419/tm2523907d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-081419
- JSON: https://secwatch.observer/filing/0001104659-25-081419.json
- Plain text: https://secwatch.observer/filing/0001104659-25-081419.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.